As of 2025-09-15, the Relative Valuation of Biohaven Pharmaceutical Holding Company Ltd (BHVN) is (106.57) USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.93 USD, the upside of Biohaven Pharmaceutical Holding Company Ltd based on Relative Valuation is -865.1%.
The range of the Relative Valuation is (100.48) - (112.66) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.9x - 15.5x | 14.7x |
| Forward P/E multiples | 13.8x - 15.6x | 14.7x |
| Fair Price | (100.48) - (112.66) | (106.57) |
| Upside | -821.4% - -908.8% | -865.1% |
| Date | P/E |
| 2025-09-10 | -1.93 |
| 2025-09-09 | -2.00 |
| 2025-09-08 | -2.00 |
| 2025-09-05 | -2.19 |
| 2025-09-04 | -2.22 |
| 2025-09-03 | -2.24 |
| 2025-09-02 | -2.19 |
| 2025-08-29 | -2.12 |
| 2025-08-28 | -2.14 |
| 2025-08-27 | -2.15 |
| 2025-08-26 | -2.17 |
| 2025-08-25 | -2.06 |
| 2025-08-22 | -2.15 |
| 2025-08-21 | -2.02 |
| 2025-08-20 | -2.03 |
| 2025-08-19 | -2.10 |
| 2025-08-18 | -2.21 |
| 2025-08-15 | -2.17 |
| 2025-08-14 | -1.96 |
| 2025-08-13 | -1.98 |
| 2025-08-12 | -1.86 |
| 2025-08-11 | -1.85 |
| 2025-08-08 | -2.03 |
| 2025-08-07 | -2.10 |
| 2025-08-06 | -2.08 |
| 2025-08-05 | -2.10 |
| 2025-08-04 | -2.03 |
| 2025-08-01 | -2.03 |
| 2025-07-31 | -2.08 |
| 2025-07-30 | -2.15 |
| 2025-07-29 | -1.77 |
| 2025-07-28 | -1.80 |
| 2025-07-25 | -1.86 |
| 2025-07-24 | -1.89 |
| 2025-07-23 | -1.90 |
| 2025-07-22 | -1.85 |
| 2025-07-21 | -1.90 |
| 2025-07-18 | -1.94 |
| 2025-07-17 | -2.08 |
| 2025-07-16 | -1.84 |
| 2025-07-15 | -1.83 |
| 2025-07-14 | -1.96 |
| 2025-07-11 | -1.92 |
| 2025-07-10 | -2.07 |
| 2025-07-09 | -2.00 |
| 2025-07-08 | -1.92 |
| 2025-07-07 | -1.90 |
| 2025-07-03 | -2.02 |
| 2025-07-02 | -2.04 |
| 2025-07-01 | -1.93 |